Repertoire Immune Medicines
Repertoire Immune Medicines is a clinical stage biotechnology company.
Funding reportedLast round: Series B
What company datasets say Repertoire Immune Medicines raised
Funding, as reported
Reported in all257.3Min the source's currency
Rounds5
Last roundSeries B
Last round dateApr 2021
Investors listed6
Founders and team
From Repertoire Immune Medicines's own website: 2 on the team.
- Regina SherwoodVice President of Human Resources
- Suzanne GrecoSenior Vice President, Finance
On a portfolio page
Investors who name them
Each firm lists Repertoire Immune Medicines on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Repertoire Immune Medicines in front of investors. Or tell us what we have wrong.